摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,6-dimethyl-2-phenylthieno[2,3-d]pyrimidin-4(3H)-one | 18593-46-9

中文名称
——
中文别名
——
英文名称
5,6-dimethyl-2-phenylthieno[2,3-d]pyrimidin-4(3H)-one
英文别名
5,6-dimethyl-2-phenyl-3H-thieno[2,3-d]pyrimidin-4-one
5,6-dimethyl-2-phenylthieno[2,3-d]pyrimidin-4(3H)-one化学式
CAS
18593-46-9
化学式
C14H12N2OS
mdl
——
分子量
256.328
InChiKey
BAYOCOYPAILNCK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    18
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    69.7
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Microwave-assisted synthesis of potent PDE7 inhibitors containing a thienopyrimidin-4-amine scaffold
    作者:Ana I. Sánchez、Ricardo Meneses、José M. Mínguez、Araceli Núñez、Rafael R. Castillo、Fabiana Filace、Carolina Burgos、Juan J. Vaquero、Julio Álvarez-Builla、Alvaro Cortés-Cabrera、Federico Gago、Emma Terricabras、Víctor Segarra
    DOI:10.1039/c4ob00175c
    日期:——

    Thienopyrimidin-4-amines have been synthesized, evaluated and modelled as phosphodiesterase inhibitors.

    噻唑嘧啶-4-胺已被合成、评估并建模为磷酸二酯酶抑制剂。
  • Exploiting Drug-Resistant Enzymes as Tools To Identify Thienopyrimidinone Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H
    作者:Takashi Masaoka、Suhman Chung、Pierluigi Caboni、Jason W. Rausch、Jennifer A. Wilson、Humeyra Taskent-Sezgin、John A. Beutler、Graziella Tocco、Stuart F. J. Le Grice
    DOI:10.1021/jm400405z
    日期:2013.7.11
    The thienopyrimidinone 5,6-dimethyl-2-(4-nitrophenyl)thieno[2,3-d]pyrimidin-4(3H)-one (DNTP) occupies the interface between the p66 ribonuclease H (RNase H) domain and p51 thumb of human immunodeficiency virus reverse transcriptase (HIV RT), thereby inducing a conformational change incompatible with catalysis. Here, we combined biochemical characterization of 39 DNTP derivatives with antiviral testing
    噻吩并嘧啶酮5,6-二甲基-2-(4-硝基苯基)噻吩并[2,3 - d ]嘧啶-4(3 H)-one (DNTP) 占据 p66 核糖核酸酶 H (RNase H) 域和人类免疫缺陷病毒逆转录酶 (HIV RT) 的 p51 拇指之间的界面,从而导致与催化不相容的构象变化。在这里,我们将 39 种 DNTP 衍生物的生化表征与所选化合物的抗病毒测试相结合。除了野生型 HIV-1 RT,还使用合理设计的 p66/p51 异二聚体对衍生物进行了评估,这些异二聚体表现出高水平的 DNTP 敏感性或抗性。该策略鉴定了 3',4'-二羟基苯基(儿茶酚)取代的噻吩并嘧啶酮,对野生型 HIV-1 RT 和耐药变体具有亚微摩尔的体外活性。热位移分析表明,与活性位点 RNase H 抑制剂相比,这些噻吩并嘧啶酮会破坏稳定酶,在某些情况下将T m降低 5 °C。重要的是,含有儿茶酚的噻吩并嘧啶酮还抑制细胞中的
  • Iodine catalysed synthesis and antibacterial evaluation of thieno-[2,3-<i>d</i>]pyrimidine derivatives
    作者:Mehdi Bakavoli、Ghodsieh Bagherzadeh、Maryam Vaseghifar、Ali Shiri、Parvaneh Pordeli
    DOI:10.3184/030823409x12537299044500
    日期:2009.11
    route via iodine catalysed heterocyclisation of 2-amino-4,5-dimethylthiophene-3-carboxamide with aromatic aldehydes affording a series of thieno[2,3-d]pyrimidine derivatives in a single step have been developed. Some of these compounds exhibited antibacterial activities comparable to Streptomycin as reference drug.
    已经开发了通过碘催化 2-氨基-4,5-二甲基噻吩-3-甲酰胺与芳香醛的杂环化,一步得到一系列噻吩并 [2,3-d] 嘧啶衍生物的新路线。这些化合物中的一些表现出与作为参考药物的链霉素相当的抗菌活性。
  • Synthesis of Some New 2-Arylthieno[2,3-d]Pyrimidin-4(3H)-One Derivatives
    作者:Abolghasem Davoodnia、Hossein Eshghi、Akram Salavaty、Niloofar Tavakoli-Hoseini
    DOI:10.3184/030823408x283685
    日期:2008.1
    Some new derivatives of 2-arylthieno[2,3-d]pyrimidin-4(3H)-ones have been prepared through a condensation reaction of 2-amino-4,5-dimethylthiophene-3-carboxamide with aroyl halides in boiling pyridine followed by cyclisation with 10% NaOH.
    通过2-氨基-4,5-二甲基噻吩-3-甲酰胺与芳酰卤在沸腾吡啶中的缩合反应,制备了2-芳基噻吩并[2,3-d]嘧啶-4(3H)-酮的一些新衍生物。用 10% NaOH 环化。
  • Synthesis and theoretical studies on energetics of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines – Their potential as adenosine receptor ligands
    作者:B. Sirisha、B. Narsaiah、T. Yakaiah、G. Gayatri、G. Narahari Sastry、M. Raghu Prasad、A. Raghuram Rao
    DOI:10.1016/j.ejmech.2009.12.075
    日期:2010.5
    A series of novel N- and O- perfluoroalkyl triazole tagged thienopyrimidines 6a-c and 7a-d was synthesized in two steps from thienopyrimidin-4-ones 2 through O- and N-propargylated regioisomers 3a-i and 4a-i respectively. Compound 2 was reacted with propargyl bromide to form O- and N-propargylated regioisomers 3 and 4 in definite proportions. Each regioisomer was separated and independently subjected to [3 + 2] cycloaddition using perfluoroalkyl azides through Click reaction under Sharpless conditions and obtained exclusively anti product in each case. The formation of two regioisomers in the first step and single anti addition product in the next step could be explained based on computational studies carried out at B3LYP/6-31G(d) level of theory. Results of Fukui function indices at the reactive centers are in accordance with the observations. On evaluation of the synthesized molecules for their binding affinities towards adenosine receptors, 4d and 4f were found to be selective to A(1) over A(2A) receptors. (C) 2010 Elsevier Masson SAS. All rights reserved.
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶